These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3020580)

  • 21. Effect of SCH 37224 on anti-IgE-induced formation of sulfidopeptide leukotrienes in human lung parenchyma.
    Viganò T; Crivellari MT; Accomazzo MR; Monopoli A; Belloni PA; Torre M; Nicosia S; Folco GC
    Eur J Pharmacol; 1992 Aug; 219(1):159-64. PubMed ID: 1397043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological profile of leukotrienes E4, N-acetyl E4 and of four of their novel omega- and beta-oxidative metabolites in airways of guinea-pig and man in vitro.
    Samhoun MN; Conroy DM; Piper PJ
    Br J Pharmacol; 1989 Dec; 98(4):1406-12. PubMed ID: 2558763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective inhibition of arachidonic acid metabolite release from human lung tissue by antiinflammatory steroids.
    Schleimer RP; Davidson DA; Lichtenstein LM; Adkinson NF
    J Immunol; 1986 Apr; 136(8):3006-11. PubMed ID: 3082976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparative study on the release of leukotrienes and histamine by guinea pig lung and trachea after challenge with antigen or stimulation with ionophore A23187 or melittin.
    Salari H
    Clin Exp Immunol; 1987 Jan; 67(1):211-9. PubMed ID: 3040307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of cyclooxygenase products in the lung action of leukotrienes A4, B4, C4, D4 and E4.
    Sirois P; Chagnon M; Borgeat P; Vallerand P
    Pharmacology; 1985; 31(4):225-36. PubMed ID: 2997811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxatomide inhibits the release of bronchoconstrictor arachidonic acid metabolites (iLTC4 and PGD2) from rat mast cells and guinea-pig lung.
    Kosaka Y; Kawabe H; Ishii A
    Agents Actions; 1987 Jun; 21(1-2):32-7. PubMed ID: 2442981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Release of leukotrienes into the perfusate of calcium-ionophore stimulated rabbit lungs. Influence of 5-lipoxygenase inhibitors.
    Schulz R; Seeger W
    Biochem Pharmacol; 1986 Jan; 35(2):183-93. PubMed ID: 3002385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The extraction of leukotrienes (LTC4, LTD4, and LTE4) from tissue fluids: the metabolism of these mediators during IgE-dependent hypersensitivity reactions in lung.
    Clancy RM; Hugli TE
    Anal Biochem; 1983 Aug; 133(1):30-9. PubMed ID: 6314841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolism of LTC4 to LTD4 and LTE4 in isolated guinea pig lung lobes.
    Kobayashi J; Kitamura S
    Prostaglandins Leukot Essent Fatty Acids; 1989 Jun; 36(3):155-7. PubMed ID: 2550966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leukotriene uptake by hepatocytes and hepatoma cells.
    Leier I; Müller M; Jedlitschky G; Keppler D
    Eur J Biochem; 1992 Oct; 209(1):281-9. PubMed ID: 1327771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Production and binding of leukotrienes in the rat brain.
    Lindgren JA; Miyamoto T; Schalling M; Hökfelt T; Samuelsson B
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():923-8. PubMed ID: 2823579
    [No Abstract]   [Full Text] [Related]  

  • 32. Leukotrienes: possible mediators in bronchial asthma.
    Piper PJ
    Eur J Respir Dis Suppl; 1983; 129():45-64. PubMed ID: 6317422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Eicosanoid release and mepyramine, LTC4 and LTD4 binding in passively sensitized human lung parenchyma in vitro.
    Crivellari MT; Accomazzo MR; Viganò T; Oliva D; Melli M; Rovati GE; Mezzetti M; Belloni P; Torre M; Verga A
    Biochem Pharmacol; 1991 Jul; 42(2):419-24. PubMed ID: 1859453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of dexamethasone on mediator release from human lung fragments and purified human lung mast cells.
    Schleimer RP; Schulman ES; MacGlashan DW; Peters SP; Hayes EC; Adams GK; Lichtenstein LM; Adkinson NF
    J Clin Invest; 1983 Jun; 71(6):1830-5. PubMed ID: 6134755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Divergent influences of leukotrienes C4, D4, and E4 on mesenteric and renal blood flow.
    Chapnick BM
    Am J Physiol; 1984 Apr; 246(4 Pt 2):H518-24. PubMed ID: 6326595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of primate bronchoalveolar mast cells. I. IgE-dependent release of histamine, leukotrienes, and prostaglandins.
    Wells E; Harper ST; Jackson CG; Mann J; Eady RP
    J Immunol; 1986 Dec; 137(12):3933-40. PubMed ID: 2431048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alveolar transfer and metabolism of eicosanoids in the rat.
    Westcott JY; McDonnell TJ; Voelkel NF
    Am Rev Respir Dis; 1989 Jan; 139(1):80-7. PubMed ID: 2536256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leukotriene synthesis by human gastrointestinal tissues.
    Dreyling KW; Hoppe U; Peskar BA; Morgenroth K; Kozuschek W; Peskar BM
    Biochim Biophys Acta; 1986 Sep; 878(2):184-93. PubMed ID: 3019409
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Release of leukotrienes C4 and B4 and prostaglandin E2 from human monocytes stimulated with aggregated IgG, IgA, and IgE.
    Ferreri NR; Howland WC; Spiegelberg HL
    J Immunol; 1986 Jun; 136(11):4188-93. PubMed ID: 3009617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IgE-dependent and ionophore-induced generation of leukotrienes by dog mastocytoma cells.
    Phillips MJ; Gold WM; Goetzl EJ
    J Immunol; 1983 Aug; 131(2):906-10. PubMed ID: 6306109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.